PATH’s approach | Providing expertise, tools, and evidence to support rotavirus vaccine access and sustainability

PATH’s philosophy is that children in the developing world should have access to safe, effective, and affordable vaccines as quickly as possible.

PATH provides technical, scientific, advocacy, and communication expertise, tools, and evidence to support the introduction of rotavirus vaccines in countries where the burden of rotavirus disease is high and children need them most urgently. As of April 27, 2013, PATH has helped the GAVI Alliance and its partners support the introduction of rotavirus vaccines in 14 low-income countries: Nicaragua (2006), Bolivia (2008), Honduras (2009), Guyana (2010), Sudan (2011), Ghana (2012), Rwanda (2012), Moldova (2012), Yemen (2012), Armenia (2012), Malawi (2012), Tanzania (2012), Georgia (2013), and Haiti (2013).

PATH deploys its approach through different avenues including:

• Accelerated Vaccine Introduction Initiative Technical Assistance Consortium (AVI TAC). Learn more
• Rotavirus Vaccine Project (RVP). Learn more

PATH also collaborates with several emerging-country vaccine manufacturers to develop a new generation of vaccine candidates into safe, effective, and affordable rotavirus vaccines for the future. Through PATH’s Vaccine Development Global Program, PATH works closely with these companies in the areas of clinical development, formulation, process development and manufacturing, and compliance with national and World Health Organization regulations, streamlining the development process and allowing these vaccines to become licensed more quickly. Learn more